Prothelia
prothelia.comLocations
Milford, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Other
founded in
2008
Prothelia is developing recombinant human laminin-111 (RHLAM-111) for treatment of Congenital Muscular Dystrophy Type 1A. This form of muscular dystrophy is also referred to as MDC1A, Merosin Deficiency, or LAMA2 Deficiency.
Something looks off?Open jobs at Prothelia
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.